Functional characterization of MLH1 missense variants unveils mechanisms of pathogenicity and clarifies role in cancer

被引:4
作者
Mahdouani, Marwa [1 ,2 ]
Ben Ahmed, Slim [3 ,4 ]
Hmila, Fahmi [4 ,5 ]
Rais, Henda [6 ]
Ben Sghaier, Rihab [1 ,2 ]
Saad, Hanene [1 ,2 ]
Ben Said, Mariem [7 ]
Masmoudi, Saber [7 ]
Hmida, Dorra [1 ,4 ]
Brieger, Angela [8 ]
Zeuzem, Stefan [8 ]
Saad, Ali [1 ,4 ]
Gribaa, Moez [1 ,4 ]
Plotz, Guido [8 ]
机构
[1] Farhat Hached Univ Hosp, Lab Human Cytogenet, Mol Genet & Reprod Biol, Sousse, Tunisia
[2] Univ Monastir, Higher Inst Biotechnol Monastir, Monastir, Tunisia
[3] Farhat Hached Univ Hosp, Dept Oncol, Sousse, Tunisia
[4] Univ Sousse, Fac Med Ibn El Jazzar Sousse, Sousse, Tunisia
[5] Farhat Hached Univ Hosp, Dept Gen & Digest Surg, Sousse, Tunisia
[6] Salah Azaiez Inst, Med Serv, Tunis, Tunisia
[7] Ctr Biotechnol Sfax, Lab Mol & Cellular Screening Proc, Sfax, Tunisia
[8] Goethe Univ, Univ Hosp, Dept Internal Med 1, Biomed Res Lab, Frankfurt, Germany
来源
PLOS ONE | 2022年 / 17卷 / 12期
关键词
MISMATCH REPAIR GENES; LYNCH-SYNDROME; MICROSATELLITE INSTABILITY; DETERMINES PATHOGENICITY; PROTEIN STABILITY; BRAF MUTATIONS; MSH2; HNPCC; METHYLATION; DEFICIENCY;
D O I
10.1371/journal.pone.0278283
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Lynch syndrome is a heritable condition caused by a heterozygous germline inactivating mutation of the DNA mismatch repair (MMR) genes, most commonly the MLH1 gene. However, one third of the identified alterations are missense variants, for which the clinical significance is unclear in many cases. We have identified three MLH1 missense alterations (p.(Glu736Lys), p.(Pro640Thr) and p.(Leu73Pro)) in six individuals from large Tunisian families. For none of these alterations, a classification of pathogenicity was available, consequently diagnosis, predictive testing and targeted surveillance in affected families was impossible. We therefore performed functional laboratory testing using a system testing stability as well as catalytic activity that includes clinically validated reference variants. Both p.(Leu73Pro) and p.(Pro640Thr) were found to be non-functional due to severe defects in protein stability and catalytic activity. In contrast, p.(Glu736Lys) was comparable to the wildtype protein and therefore considered a neutral substitution. Analysis of residue conservation and of the structural roles of the substituted residues corroborated these findings. In conjunction with the available clinical data, two variants fulfil classification criteria for class 4 "likely pathogenic". The findings of this work clarify the mechanism of pathogenicity of two unclear MLH1 variants and enables predictive testing and targeted surveillance in members of carrier families worldwide.
引用
收藏
页数:17
相关论文
共 68 条
  • [1] Computational and cellular studies reveal structural destabilization and degradation of MLH1 variants in Lynch syndrome
    Abildgaard, Amanda B.
    Stein, Amelie
    Nielsen, Sofie V.
    Schultz-Knudsen, Katrine
    Papaleo, Elena
    Shrikhande, Amruta
    Hoffmann, Eva R.
    Bernstein, Inge
    Gerdes, Anne-Marie
    Takahashi, Masanobu
    Ishioka, Chikashi
    Lindorff-Larsen, Kresten
    Hartmann-Petersen, Rasmus
    [J]. ELIFE, 2019, 8
  • [2] Lynch syndrome in Tunisia: first description of clinical features and germline mutations
    Aissi-Ben Moussa, Sana
    Moussa, Amel
    Kourda, Nadia
    Mezlini, Amel
    Abdelli, Nabil
    Zerimech, Farid
    Najjar, Taoufik
    Ben Jilani, Sarah
    Porchet, Nicole
    Ben Ayed, Farhat
    Manai, Mohamed
    Buisine, Marie-Pierre
    [J]. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2011, 26 (04) : 455 - 467
  • [3] Biomarkers and clinical scores to aid the identification of disease severity and intensive care requirement following activation of an in-hospital sepsis code
    Baldira, Jaume
    Ruiz-Rodriguez, Juan Carlos
    Wilson, Darius Cameron
    Ruiz-Sanmartin, Adolf
    Cortes, Alejandro
    Chiscano, Luis
    Ferrer-Costa, Roser
    Comas, Inma
    Larrosa, Nieves
    Fabrega, Anna
    Gonzalez-Lopez, Juan Jose
    Ferrer, Ricard
    [J]. ANNALS OF INTENSIVE CARE, 2020, 10 (01)
  • [4] Targeted next generation sequencing screening of Lynch syndrome in Tunisian population
    Ben Sghaier, Rihab
    Jansen, Anne Maria Lucia
    Bdioui, Ahlem
    Van Wezel, Tom
    Ksiaa, Mehdi
    Elgolli, Lamia
    Ben Fatma, Leila
    Ben Ahmed, Slim
    Azzouz, Mohamed Msaddak
    Hellara, Olfa
    Elghali, Amine
    Darbel, Fathi
    Skandrani, Karim
    Mokkni, Moncef
    Gdissa, Ameni
    Ltaief, Rached
    Saad, Ali
    Hmila, Fahmi
    Gribaa, Moez
    Morreau, Hans
    [J]. FAMILIAL CANCER, 2019, 18 (03) : 343 - 348
  • [5] Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2010.04.024, 10.1053/j.gastro.2009.12.064]
  • [6] Comprehensive functional assessment of MLH1 variants of unknown significance
    Borras, Ester
    Pineda, Marta
    Brieger, Angela
    Hinrichsen, Inge
    Gomez, Carolina
    Navarro, Matilde
    Balmana, Judit
    Ramon y Cajal, Teresa
    Torres, Asuncion
    Brunet, Joan
    Blanco, Ignacio
    Plotz, Guido
    Lazaro, Conxi
    Capella, Gabriel
    [J]. HUMAN MUTATION, 2012, 33 (11) : 1576 - 1588
  • [7] The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments
    Bustin, Stephen A.
    Benes, Vladimir
    Garson, Jeremy A.
    Hellemans, Jan
    Huggett, Jim
    Kubista, Mikael
    Mueller, Reinhold
    Nolan, Tania
    Pfaffl, Michael W.
    Shipley, Gregory L.
    Vandesompele, Jo
    Wittwer, Carl T.
    [J]. CLINICAL CHEMISTRY, 2009, 55 (04) : 611 - 622
  • [8] Concomitant mutation and epimutation of the MLH1 gene in a Lynch syndrome family
    Cini, Giulia
    Carnevali, Ileana
    Quaia, Michele
    Chiaravalli, Anna Maria
    Sala, Paola
    Giacomini, Elisa
    Maestro, Roberta
    Tibiletti, Maria Grazia
    Viel, Alessandra
    [J]. CARCINOGENESIS, 2015, 36 (04) : 452 - 458
  • [9] Methylation tolerance in mismatch repair proficient cells with low MSH2 protein level
    Claij, N
    Riele, HT
    [J]. ONCOGENE, 2002, 21 (18) : 2873 - 2879
  • [10] Lynch Syndrome: From Screening to Diagnosis to Treatment in the Era of Modern Molecular Oncology
    Cohen, Stacey A.
    Pritchard, Colin C.
    Jarvik, Gail P.
    [J]. ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS, VOL 20, 2019, 2019, 20 : 293 - 307